Literature DB >> 22362863

Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.

Christian Theilacker1, Andrea Kropec, Felix Hammer, Irina Sava, Dominique Wobser, Tuerkan Sakinc, Jeroen D C Codée, Wouter F J Hogendorf, Gijsbert A van der Marel, Johannes Huebner.   

Abstract

Type 1 lipoteichoic acid (LTA) is present in many clinically important gram-positive bacteria, including enterococci, streptococci, and staphylococci, and antibodies against LTA have been shown to opsonize nonencapsulated Enterococcus faecalis strains. In the present study, we show that antibodies against E. faecalis LTA also bind to type 1 LTA from other gram-positive species and opsonized Staphylocccus epidermidis and Staphylcoccus aureus strains as well as group B streptococci. Inhibition studies using teichoic acid oligomers indicated that cross-reactive opsonic antibodies bind to the teichoic acid backbone. Passive immunization with rabbit antibodies against E. faecalis LTA promoted the clearance of bacteremia by E. faecalis and S. epidermidis in mice. Furthermore, passive protection also reduced mortality in a murine S. aureus peritonitis model. The effectiveness of rabbit antibody against LTA suggests that this conserved bacterial structure could function as a single vaccine antigen that targets multiple gram-positive pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362863     DOI: 10.1093/infdis/jis022

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Phagocytosis and killing of Staphylococcus aureus by human neutrophils.

Authors:  Thea Lu; Adeline R Porter; Adam D Kennedy; Scott D Kobayashi; Frank R DeLeo
Journal:  J Innate Immun       Date:  2014-04-05       Impact factor: 7.349

2.  Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.

Authors:  N Misra; T F Wines; C L Knopp; R Hermann; L Bond; B Mitchell; M A McGuire; J K Tinker
Journal:  Vaccine       Date:  2018-05-05       Impact factor: 3.641

Review 3.  Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research.

Authors:  Swantje Voller; H Rob Taal; Serife Kurul; Kinga Fiebig; Robert B Flint; Irwin K M Reiss; Helmut Küster; Sinno H P Simons
Journal:  Pediatr Res       Date:  2021-09-08       Impact factor: 3.756

4.  Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin.

Authors:  Stefan Geiss-Liebisch; Suzan H M Rooijakkers; Agnieszka Beczala; Patricia Sanchez-Carballo; Karolina Kruszynska; Christian Repp; Tuerkan Sakinc; Evgeny Vinogradov; Otto Holst; Johannes Huebner; Christian Theilacker
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 5.  Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Authors:  Cuong Vuong; Anthony J Yeh; Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Investig Drugs       Date:  2015-11-04       Impact factor: 6.206

6.  Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.

Authors:  Quanyi Chen; Jay Dintaman; Andrew Lees; Goutam Sen; David Schwartz; Mark E Shirtliff; Saeyoung Park; Jean C Lee; James J Mond; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

7.  In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens.

Authors:  F S Rossmann; A Kropec; D Laverde; F R Saaverda; D Wobser; J Huebner
Journal:  Infection       Date:  2014-11-27       Impact factor: 3.553

8.  Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels.

Authors:  Soeren Ocvirk; Irina G Sava; Isabella Lengfelder; Ilias Lagkouvardos; Natalie Steck; Jung H Roh; Sandrine Tchaptchet; Yinyin Bao; Jonathan J Hansen; Johannes Huebner; Ian M Carroll; Barbara E Murray; R Balfour Sartor; Dirk Haller
Journal:  PLoS Pathog       Date:  2015-06-12       Impact factor: 6.823

9.  Isolation of highly active monoclonal antibodies against multiresistant gram-positive bacteria.

Authors:  Friederike S Rossmann; Diana Laverde; Andrea Kropec; Felipe Romero-Saavedra; Melanie Meyer-Buehn; Johannes Huebner
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

10.  The 2.5 Å structure of the enterococcus conjugation protein TraM resembles VirB8 type IV secretion proteins.

Authors:  Nikolaus Goessweiner-Mohr; Lukas Grumet; Karsten Arends; Tea Pavkov-Keller; Christian C Gruber; Karl Gruber; Ruth Birner-Gruenberger; Andrea Kropec-Huebner; Johannes Huebner; Elisabeth Grohmann; Walter Keller
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.